Ampio terminates at-the-market equity offering agreement with H.C. Wainwright

Ampio Pharmaceuticals, Inc.

Termination notice issued Feb 26, 2024; effective March 6, 2024.
Filed post-effective amendment to withdraw all unsold shares from registration.
ATM program originally established September 18, 2023.
No securities sold under the program since termination.

item 1.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Ampio Pharmaceuticals, Inc. terminated ATM Agreement with H.C. Wainwright & Co., LLC (effective 2024-02-26).

Action: termination
Agreement: atm program
Counterparty: H.C. Wainwright & Co., LLC
Effective: 2024-02-26

Exact text from the filing

On February 26, 2024, Ampio Pharmaceuticals, Inc. (the “Company”) provided a notice to H.C. Wainwright & Co., LLC to terminate that certain At The Marketing Offering Agreement, dated September 18, 2023, by and between the Company and H.C. Wainwright & Co., LLC (the “ATM Agreement”), establishing an at-the-market equity distribution program for the offer and sale from time to time shares of the Company’s common stock, par value $0.0001.

View on SEC.gov

754 material agreements filed in the last 30 days. Browse all material agreements →

Source: SEC EDGAR

accession 0001558370-24-001983

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.